首页> 外文期刊>Dalton transactions: An international journal of inorganic chemistry >Chiral multidentate oxazoline ligands based on cyclophosphazene cores: synthesis, characterization and complexation studies
【24h】

Chiral multidentate oxazoline ligands based on cyclophosphazene cores: synthesis, characterization and complexation studies

机译:基于环磷腈核的手性多齿恶唑啉配体:合成,表征和络合研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Chiral oxazoline based bi and hexadentate ligands built on cyclophosphazene cores have been synthesized and characterized. (NPPh_2)_2[NP(m-OC_6H_4C(O)OCH_3)_2] (1) was prepared by the reaction of gem- (NPPh_2)_2(NPCl_2) with methyl-3-hydroxy benzoate in the presence of Cs_2CO_3. Compound 1 was converted to the dicarboxylic acid (NPPh_2)_2[NP(m-OC_6H_4C(O)OH)_2] (2) by base promoted hydrolysis with KO- (t-Bu). The dicarboxylic acid 2 on reaction with oxalyl chloride followed by (S)-(+)-2-amino-3-methyl-1- butanol, triethylamine and mesyl chloride was converted to the C_2-symmetric phosphazene based chiral bisoxazoline ligand (NPPh_2)_2[NP{m-OC_6H_4(4-iPr-2-Ox)}_2] (3) (Ox = oxazolinyl). A similar C_2-symmetric bisoxazoline derivative having an oxazoline group attached to the para position of the phenyl ring was also synthesized starting from (NPPh_2)_2[NP(p-OC_6H_4C(O)OCH_3)_2] (4) which was first converted to the dicarboxylic acid (NPPh_2)_2[NP(p-OC_6H_4C(O)OH)_2] (5) and finally to (NPPh_2)_2[NP{p-OC_6H_4(4-iPr-2-Ox)}_2] (6) and (NPPh_2)_2[NP{p-OC_6H_4(4-Ph-2-Ox)}_2] (7) under similar reaction conditions. Reaction of 6 with Pd(OAc)_2 in acetic acid at room temperature and with PdCl_2(C_6H_5CN)_2 in refluxing benzene resulted in chiral palladium complexes Pd(OAc)_2(NPPh_2)_2[NP{p-OC_6H_4(4-iPr-2-Ox)}_2] (8) and PdCl_2(NPPh_2)_2[NP{p- OC_6H_4(4-iPr-2-Ox)}_2] (9), respectively. The utility of these palladium complexes as chiral catalysts for the asymmetric rearrangement of trichloroacetimidates to trichloroacetamides has been explored. The hexa (methylbenzoate) derivative of cyclophosphazene [PN(OC_6H_4COOCH_3)_2]_3 (10) on treatment with KO(t- Bu) and H_2O gave the hexacarboxylic acid derivative [PN(OC_6H_4COOH)_2]_3 (11), which on treatment with oxalyl chloride followed by (S)-(+)-2-amino-3-methyl-1-butanol/(S)-(+)-2-phenylglycinol, triethylamine and mesyl chloride was converted to the C_3-symmetric cyclophosphazene based chiral hexaoxazoline ligands [PN{OC_6H_4(4-iPr-2-Ox)}_2]3 (12) and [PN{OC_6H_4(4-Ph-2-Ox)}_2]_3 (13). The bis(phebox) derivative of the cyclophosphazene was prepared starting from (NPPh_2)_2[NP{OC_6H_3(COOCH_3)_2}_2] (14), by the reaction of gem-Ph_4P_3N_3Cl_2 with dimethyl 5-hydroxyisophthalate in the presence of Cs_2CO_3. Compound 14 was converted to the tetracarboxylic acid (NPPh_2)_2[NP{OC_6H_3(COOH)_2}_2] (15) by base promoted hydrolysis with KO(t-Bu). The tetracarboxylic acid 15 on reaction with oxalyl chloride followed by (S)-(+)-2-amino- 3-methyl-1-butanol/(S)-(+)-2-phenylglycinol, triethylamine and mesyl chloride was converted to the bis- (phebox) substituted tetraphenylcyclophosphazene derivatives (NPPh_2)_2[NP{OC_6H_3(4-iPr-2-Ox)_2}_2] (16)/ (NPPh_2)_2[NP{OC_6H_3(4-Ph-2-Ox)_2}_2] (17). A similar tetra(phebox) derivative was synthesized from (NPPh_2)- [NP{OC_6H_3(COOCH_3)_2}_2]_2 (18) which was first converted to (NPPh_2)[NP{OC_6H_3(COOH)_2}_2]_2 (19) and further converted to the tetra(phebox) derivative (NPPh_2) [NP{OC_6H_3(4-Ph-2-Ox)_2}_2]_2 (20). All new compounds were characterized by IR, NMR [~1H, ~(13)C{~1H} and ~(31)P{~1H}] and HRMS studies. Compounds 1, 2, 4, 5, 7, 14 and 18 have also been structurally characterized.
机译:已经合成和表征了基于手性恶唑啉的基于环磷腈核的双和六齿配体。 (NPPh_2)_2 [NP(m-OC_6H_4C(O)OCH_3)_2](1)通过在Cs_2CO_3存在下,gem-(NPPh_2)_2(NPCl_2)与-3-羟基苯甲酸甲酯反应制得。通过用KO-(t-Bu)进行碱促进的水解,将化合物1转化为二羧酸(NPPh_2)_2 [NP(m-OC_6H_4C(O)OH)_2](2)。与草酰氯反应的二羧酸2,然后与(S)-(+)-2-氨基-3-甲基-1-丁醇,三乙胺和甲磺酰氯反应,转化为基于C_2对称磷腈的手性双恶唑啉配体(NPPh_2) _2 [NP {m {OC-6H_4(4-iPr-2-Ox)} _ 2](3)(Ox =恶唑啉基)。还从(NPPh_2)_2 [NP(p-OC_6H_4C(O)OCH_3)_2](4)开始合成了类似的具有连接至苯环对位的恶唑啉基团的C_2-对称双恶唑啉衍生物二羧酸(NPPh_2)_2 [NP(p-OC_6H_4C(O)OH)_2](5),最后变成(NPPh_2)_2 [NP {p-OC_6H_4(4-iPr-2-Ox)} _ 2](6 )和(NPPh_2)_2 [NP {p-OC_6H_4(4-Ph-2-Ox)} _ 2](7)在相似的反应条件下。 6在室温下与Pd(OAc)_2在乙酸中的反应以及在回流的苯中与PdCl_2(C_6H_5CN)_2的反应生成手性钯配合物Pd(OAc)_2(NPPh_2)_2 [NP {p-OC_6H_4(4-iPr- 2-Ox)} _ 2](8)和PdCl_2(NPPh_2)_2 [NP {pOC_6H_4(4-iPr-2-Ox)} _ 2](9)。已经探索了这些钯配合物作为手性催化剂用于将三氯乙亚氨酸酯不对称重排为三氯乙酰胺的方法。环磷腈[PN(OC_6H_4COOCH_3)_2] _3(10)的六(甲基苯甲酸酯)衍生物经KO(t-Bu)和H_2O处理后得到六羧酸衍生物[PN(OC_6H_4COOH)_2] _3(11)先用草酰氯,然后用(S)-(+)-2-氨基-3-甲基-1-丁醇/(S)-(+)-2-苯基甘氨醇,三乙胺和甲磺酰氯转化为C_3对称环磷腈手性六恶唑啉配体[PN {OC_6H_4(4-iPr-2-Ox)} _ 2] 3(12)和[PN {OC_6H_4(4-Ph-2-Ox)} _ 2] _3(13)。环磷腈的双(phebox)衍生物是由(NPPh_2)_2 [NP {OC_6H_3(COOCH_3)_2} _2] _2](14)在Ges-Ph_4P_3N_3Cl_2与5-羟基间苯二甲酸二甲酯在Cs_2CO_3存在下反应制备的。通过用KO(t-Bu)进行碱促进的水解,将化合物14转化为四羧酸(NPPh_2)_2 [NP {OC_6H_3(COOH)_2} _2](15)。与草酰氯反应,然后与(S)-(+)-2-氨基-3-甲基-1-丁醇/(S)-(+)-2-苯基甘醇,三乙胺和甲磺酰氯反应的四羧酸15被转化为双(phebox)取代的四苯基环磷腈衍生物(NPPh_2)_2 [NP {OC_6H_3(4-iPr-2-Ox)_2} _2](16)/(NPPh_2)_2 [NP {OC_6H_3(4-Ph-2-Ox )_2} _2](17)。由(NPPh_2)-[NP {OC_6H_3(COOCH_3)_2} _2] _2(18)合成了类似的四(phebox)衍生物,该衍生物首先被转化为(NPPh_2)[NP {OC_6H_3(COOH)_2} _2] _2] _2( 19)并进一步转化为四(phebox)衍生物(NPPh_2)[NP {OC_6H_3(4-Ph-2-Ox)_2} _2] _2(20)。所有新化合物均通过IR,NMR [〜1H,〜(13)C {〜1H}和〜(31)P {〜1H}]和HRMS研究进行了表征。化合物1、2、4、5、7、14和18的结构也已表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号